Article
Analysis of MEF2A mutations in a Chinese population with premature coronary artery disease.
Genetic testing and molecular biomarkers - 1 Apr 2013
Dai Yuxiang, Zhang Shuyang, Wu Wei
Abstract excerpt
AIMS: To assess the relationship between mutations of the myocyte enhancer factor 2A (MEF2A) and premature coronary artery disease (PCAD) in a Chinese population. METHODS AND RESULTS: The mutations in the exons 8 and 12 of the MEF2A gene were analyzed in both PCAD families and sporadic cases using direct sequencing of polymerase chain reaction products. In one PCAD family, seven members of the third generation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
